Rethinking the Preoperative Hold in Patients on Incretin TherapyA patient on incretin therapy is scheduled for a colonoscopy, and the reflex is immediate: hold the drug. That reflex is three years old, it came from...3 min read
Quiz for Clinicians – Monitoring Patients on GLP-1 TherapyStarting therapy is the straightforward part. These five questions cover what monitoring patients on GLP-1 therapy requires once treatment is established—nutritional status,...1 min read
Quiz for Clinicians – GLP-1 Prescribing ConsiderationsEvery prescription in this class lands on top of a medication list that was already there. These five questions cover the GLP-1...1 min read
Assessing Function Before Initiating GLP-1 Therapy in Older AdultsMedicare coverage for weight management under the GLP-1 Bridge demonstration is authorized through December 31, 2027, and the eligible population is broader than many clinicians assume...4 min read
Selecting the Right Bridge-Covered GLP-1 for Older Patients With ObesityGlucagon-like peptide-1 (GLP-1) receptor agonists and dual incretin agents have transformed obesity medicine, yet access for older patients remains uneven...3 min read
Quiz for Clinicians – Test Your Knowledge Around Obesity ManagementThink you're up to speed on the fastest-moving areas of obesity care? This five-question quiz covers managing GLP-1 side effects...1 min read
Integrating GLP-1 Management into the Medicare Annual Wellness Visit (AWV)The landscape of obesity management for the Medicare population is undergoing a seismic shift. With the recent launch of...4 min read
Optimizing Multi-Morbidity Management for 65+ Population Using GLP-1 TherapyThe clinical management of the geriatric patient has long been defined by a precarious balancing act: the challenge of treating chronic conditions...3 min read
Navigating the 2026 Medicare GLP-1 Bridge and Patient Expectations for GLP-1 TherapyThe clinical landscape for obesity management in the United States is undergoing a transformative shift. For years, clinicians and their older patients faced...3 min read
An Operational Guide for GLP-1 Prescribing Under the 2026 Medicare Bridge ProgramAs of 2026, the obesity management landscape has undergone a seismic shift with the launch of the Medicare GLP-1 Bridge Program. For years, clinicians have navigated...4 min read
Mitigating Sarcopenia Risk in Older GLP-1 PatientsWhile GLP-1s have demonstrated unprecedented efficacy in weight reduction and metabolic improvement, their success introduces a secondary challenge for the geriatric population...3 min read
Managing Gastrointestinal Sensitivity and Dehydration Risks in Seniors on GLP-1 TherapyThe clinical landscape of obesity management has been fundamentally transformed by the advent of glucagon-like peptide-1 receptor agonists (GLP-1s) and...3 min read
Hear+Now: An AI-Powered Podcast – Why the Medicare GLP-1 Bridge Could Be Crucial for Seniors with Mobility-Limiting ComorbiditiesAs the regulatory landscape for metabolic health continues to evolve, new federal initiatives are redefining the standard of care and access...4 min read
Obesity Quiz for CliniciansObesity medicine moves fast. Staying current is no longer just about the scale; it’s about navigating...1 min read
Quiz for Clinicians – GLP-1 Safety and Coverage in Older AdultsSix weeks into the Medicare GLP-1 Bridge, the practical questions have shifted from whether a patient qualifies to how therapy is...1 min read
